Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Melanoma/Skin Cancer
•
Dermatology
Are there certain patient characteristics that drive you to recommend intralesional 5-FU or MTX for a large SCC on the back?
Related Questions
How would you palliate a large, symptomatic vaginal melanoma recurrence with limited small pelvic lymph node metastases?
Do you obtain MRI for cutaneous SCC with microscopic PNI to assess for gross perineural tumor spread?
How do you approach patients with advanced resectable basal cell carcinoma for possible use of hedgehog inhibitors?
What’s your approach to treating multiple facial BCCs in gorlin syndrome?
What chemoprophylaxis, if any, would you consider in a transplant patient with numerous KC/NMSCs?
Is narrow-band ultraviolet B (nbUVB) phototherapy contraindicated or recommended with caution in patients with a personal history of melanoma?
What patient characteristics or clinical scenarios guide the decision in performing slow Mohs procedures?
How do you approach melanoma patients with a positive sentinel node with extra-nodal extension for definitive surgical management?
Do computerized mole-mapping tools play a role in your clinical practice?
What is your experience with itraconazole as a primary or adjunct therapy for individuals with numerous BCCs?
